Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. 27854360

2017

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. 25356965

2015

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. 25394175

2015

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. 24893135

2014

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. 23788249

2013

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Clinical utility gene card for: multiple endocrine neoplasia type 2. 21863057

2012

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation BEFREE MEN2A (C618S), MEN2A/familial MTC (FMTC) (C620S), and MEN2B (M918T). 22199277

2011

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Medullary thyroid cancer: management guidelines of the American Thyroid Association. 19469690

2009

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT Guidelines for diagnosis and therapy of MEN type 1 and type 2. 11739416

2001

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation UNIPROT The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. 8918855

1996

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation BEFREE Two mutations (C609Y and C620R) we identified have previously been associated with multiple endocrine neoplasia type 2A (MEN2A), medullary thyroid carcinoma (MTC) and, on rare occasions, HSCR. 7633441

1995

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
0.830 GeneticVariation BEFREE We have identified a mutation in codon 620, 2053 T-->C (Cys620Arg), and two mutations in codon 634 of exon 11 of RET, 2095 T-->C (Cys634Arg) and 2096 G-->A (Cys634Tyr), all three of which were present in both MEN2A and FMTC families. 7835899

1994

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
G 0.830 CausalMutation CLINVAR

dbSNP: rs77316810
rs77316810
RET
Multiple Endocrine Neoplasia Type 2a
C 0.830 CausalMutation CLINVAR